Global Neurostimulation Devices Market Value to Increase to US$ 10,445.7 Million by 2020

Neurostimulation devices are commonly used for diagnosing and treating disorders of autonomic nerves system (ANS), central nerves system (CNS) and peripheral nervous system (PNS). Neurostimulation devices are used for stimulation of brain cells and for administering medication. Diseases that do not react or respond to systematic drug therapies need advanced stimulation devices for treating them. Demand for such devices are growing, especially for managing chronic neurological conditions such as nociceptive pain, neuropathic pain, epilepsy, depression and parkinson’s disease. In addition, higher cases of nociceptive pain arising from diseases such as cancer, arthritis and diabetes is compelling healthcare experts and manufacturers to jointly work on developing enhanced models of neurostimulation devices. In 2014, the global neurostimulation devices market was valued at US$ 5,088.9 Million. PMR forecast that the global neurostimulation devices market will register a CAGR of above 12% to reach US$ 10,445.7 Million by 2020.

PMR indicates that the global neurostimulation devices market will primarily be driven by increasing incidences of neurological diseases and higher occurrence of associated chronic pain and discomfort. On contrary, factors such as increasing geriatric population, growing awareness on better neurological treatment and advancement in functionality of neurostimulation devices are expected to equally influence the overall growth of market during the forecast period. In contrast, side-effects and risks associated with neurostimulation therapy and availability of other options of treatment for neurological disorders are some of the negative factors likely to hinder the market growth.

The global neurostimulation devices market has been classified into device type, by application and by region.

On the basis of device type, the market is segmented into implantable device and external device. In addition, the implantable device segment is further sub-segmented into, cochlear implants (CI), sacral nerve stimulation (SNS), gastric electric stimulation (GES), deep brain stimulation (DBS), vagus nerve stimulation (VNS) and spinal cord stimulation (SCS). The external device segment is bifurcated into transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Based on application, the market is segmented into parkinson’s disease, epilepsy, urinary and fecal incontinence, gastroparesis, pain management, hearing loss and depression.

A Sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/2824

Based on geography, the global neurostimulation devices market is segmented into four key regions namely North America, Asia Pacific, Europe and rest of the world (RoW). North America is in pole position of the global neurostimulation devices market, which is largely attributed to the growing prevalence of neurological disorders in the region. In addition, various private and government organizations in the region are frequently running awareness campaigns on neurological disorders and associated health impediments. Likewise, availability of advanced neurological treatments is also adding up significantly to the market growth in the region. The neurostimulation devices market in Europe, is largely expanding due to several healthcare initiatives taken by various public organizations to improve the healthcare sector in the region. Further, the market in Asia Pacific is expected to register the fastest growth rate during the forecast period primarily due to the increasing incidences of neurological disorders such as arthritis and osteoporosis in countries such as Japan and China.

Request to view Table of content @ http://www.persistencemarketresearch.com/market-research/neurostimulation-devices-market/toc

Key participants identified in the global neurostimulation devices market include Boston Scientific Corporation, St. Jude Medical, Inc., Cochlear, Ltd., Medtronic, Plc, NDI Medical, LLC, MED-EL., Cyberonics, Inc., NeuroSigma, Inc., and NeuroPace, Inc.,

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/2824

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.